Cornerstone Capital Management Holdings LLC. reduced its position in shares of China Biologic Products, Inc. (NASDAQ:CBPO) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 277,281 shares of the biopharmaceutical company’s stock after selling 1,269 shares during the period. Cornerstone Capital Management Holdings LLC. owned approximately 1.02% of China Biologic Products worth $31,360,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. Oppenheimer Asset Management Inc. acquired a new position in China Biologic Products in the 1st quarter valued at $156,000. Nomura Holdings Inc. acquired a new position in China Biologic Products in the 1st quarter valued at $463,000. Jennison Associates LLC raised its holdings in China Biologic Products by 0.8% in the 2nd quarter. Jennison Associates LLC now owns 5,775 shares of the biopharmaceutical company’s stock valued at $653,000 after acquiring an additional 44 shares in the last quarter. AHL Partners LLP acquired a new position in China Biologic Products in the 2nd quarter valued at $842,000. Finally, First Trust Advisors LP raised its holdings in China Biologic Products by 35.9% in the 1st quarter. First Trust Advisors LP now owns 11,561 shares of the biopharmaceutical company’s stock valued at $1,158,000 after acquiring an additional 3,053 shares in the last quarter. 72.82% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Cornerstone Capital Management Holdings LLC. Reduces Position in China Biologic Products, Inc. (CBPO)” was published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.watchlistnews.com/cornerstone-capital-management-holdings-llc-reduces-position-in-china-biologic-products-inc-cbpo/1610927.html.

Shares of China Biologic Products, Inc. (NASDAQ CBPO) traded down 0.53% during trading on Thursday, reaching $96.52. The company’s stock had a trading volume of 17,788 shares. The stock has a market cap of $2.63 billion, a P/E ratio of 25.12 and a beta of 1.75. China Biologic Products, Inc. has a 52-week low of $88.25 and a 52-week high of $125.99. The stock has a 50-day moving average of $92.76 and a 200-day moving average of $103.46.

China Biologic Products (NASDAQ:CBPO) last posted its earnings results on Wednesday, August 2nd. The biopharmaceutical company reported $1.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.05. The firm had revenue of $89.28 million for the quarter, compared to the consensus estimate of $97.33 million. China Biologic Products had a return on equity of 21.86% and a net margin of 31.55%. The business’s quarterly revenue was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.26 earnings per share. Analysts predict that China Biologic Products, Inc. will post $4.96 earnings per share for the current fiscal year.

Several brokerages have weighed in on CBPO. Jefferies Group LLC reaffirmed a “buy” rating on shares of China Biologic Products in a report on Friday, August 4th. BidaskClub cut China Biologic Products from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Finally, Zacks Investment Research cut China Biologic Products from a “hold” rating to a “sell” rating in a report on Monday, August 7th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company. China Biologic Products has an average rating of “Hold” and a consensus target price of $137.50.

About China Biologic Products

Want to see what other hedge funds are holding CBPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for China Biologic Products, Inc. (NASDAQ:CBPO).

Institutional Ownership by Quarter for China Biologic Products (NASDAQ:CBPO)

Receive News & Ratings for China Biologic Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Biologic Products Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.